You are here

Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. II. Effects on microbial proliferation and host survival in vivo.

TitleAntimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. II. Effects on microbial proliferation and host survival in vivo.
Publication TypeJournal Article
Year of Publication2000
AuthorsMastroeni, P, Vazquez-Torres, A, Fang, FC, Xu, Y, Khan, S, Hormaeche, CE, Dougan, G
JournalJ Exp Med
Volume192
Issue2
Pagination237-48
Date Published2000 Jul 17
ISSN0022-1007
KeywordsAnimals, Flow Cytometry, Interferon-gamma, Membrane Glycoproteins, Mice, Mice, Inbred C57BL, NADPH Oxidase, Nitric Oxide Synthase, Nitric Oxide Synthase Type II, Salmonella Infections, Animal, Salmonella typhimurium
Abstract

The roles of the NADPH phagocyte oxidase (phox) and inducible nitric oxide synthase (iNOS) in host resistance to virulent Salmonella typhimurium were investigated in gp91phox(-/)-, iNOS(-/)-, and congenic wild-type mice. Although both gp91phox(-/)- and iNOS(-/)- mice demonstrated increased susceptibility to infection with S. typhimurium compared with wild-type mice, the kinetics of bacterial replication were dramatically different in the gp91phox(-/)- and iNOS(-/)- mouse strains. Greater bacterial numbers were present in the spleens and livers of gp91phox(-/)- mice compared with C57BL/6 controls as early as day 1 of infection, and all of the gp91phox(-/)- mice succumbed to infection within 5 d. In contrast, an increased bacterial burden was detected within reticuloendothelial organs of iNOS(-/)- mice only beyond the first week of infection. Influx of inflammatory CD11b(+) cells, granuloma formation, and serum interferon gamma levels were unimpaired in iNOS(-/)- mice, but the iNOS-deficient granulomas were unable to limit bacterial replication. The NADPH phagocye oxidase and iNOS are both required for host resistance to wild-type Salmonella, but appear to operate principally at different stages of infection.

Alternate JournalJ. Exp. Med.
PubMed ID10899910
PubMed Central IDPMC2193252
Grant ListAI110181 / AI / NIAID NIH HHS / United States
AI39557 / AI / NIAID NIH HHS / United States
AI44486 / AI / NIAID NIH HHS / United States